Please ensure Javascript is enabled for purposes of website accessibility

What Everybody Ought to Know About athenahealth's Noisy 2014 Guidance

By Todd Campbell - Dec 17, 2013 at 1:49PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

athenahealth's guidance for 2014 put investors on a roller coaster last week. Here's what you need to know about the forecast.

Investors had good reason to be worried over athenahealth's (ATHN) share price slide last week. After all, the company trades at a jaw-dropping 119 times expected earnings per share.

But plenty of companies with 100 plus P/E ratios make shareholders money. jumps to mind. Motley Fool co-founder David Gardner has owned that company for more than a decade, and he got a 100-bagger from it.

So, instead of worrying over athenahealth's lofty P/E, it may be more useful to see if the market for the company's products has more room to grow. After all, sometimes good companies stumble, presenting opportunities for long-term investors to take advantage of sale prices.

The market for medical records
As of the end of September, 47,195 providers were using athenahealth's software network to manage patient records. Yet that only scratches the surface of the addressable market. Athenahealth's market share in the physician medical records market stood at just 2.3% at the end of May -- after increasing 35% from a year ago.

Athenahealth's recently acquired Epocrates mobile app business has been downloaded by more than 300,000 doctors, suggesting that there's plenty more physicians for athenahealth to market its EHR systems.

Competing for share
Athenahealth's most direct competitors in the physician EHR space are Quality Systems (NXGN -0.83%), with 75,000 customers, and GE Healthcare (GE -0.55%). All three of these competitors have an opportunity to grow as doctors rush to implement solutions in order to qualify for incentive payments tied to the Affordable Care Act's Meaningful Use provision.

That rush is accelerating as spending on health care IT solutions grows from $89.7 billion to $184.5 billion in 2020. Couple the bump in spending along with the fact 50% of the market for physician EHR systems is still controlled by more than 400 small regional EHR players, and there's a good opportunity for athenahealth, Quality Systems, and GE Healthcare to win business.

Debating earnings
However, sales growth hasn't really been investors' major concern for athenahealth. Instead, it has been earnings.

Last December, investors knocked athenahealth down 7% over worries tied to its 2013 guidance, which was looking for $525 million to $550 million in sales. Yet shares still gained 80% this year, even when including the 10% fall last week following athenahealth's 2014 guidance.

And athenahealth's outlook for 2014 isn't horrible. The company expects $580 million to $615 million in revenue projection this year, well above last year's guidance, and $725 million to $755 million in sales for 2014. Even if we use the high end of 2013 and the low end of 2014, that projection works out to 18% growth next year and 72% growth from 2012

Instead, it's likely that investors are worrying over athenahealth's earnings outlook for 2014. The company plans to plow money back into developing its software next year, which may drop operating margin from 11.7% to 13% this year to an estimated 9.7% to 10.6% next year. That drop in margin suggests earnings per share will be $0.98 to $1.10 in 2014, down from $1.05 to $1.15 this year.

Foolish final thoughts
Athenahealth operates in a fast growing market that's requiring plenty of investment to stay ahead of competitors Quality Systems and GE Healthcare. So investors should take athenahealth's eye-popping P/E ratio with a grain of salt. After all, if athenahealth can continue to win providers over to its cloud-based records system, it will build enough scale to allow it to address the margin issue later. That suggests that investors should keep a close eye on industry projections for the coming decade to see if they rise or fall, because that may have a bigger impact on whether shares ultimately go higher or lower.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

athenahealth, Inc. Stock Quote
athenahealth, Inc.
General Electric Company Stock Quote
General Electric Company
$66.71 (-0.55%) $0.37
NextGen Healthcare, Inc Stock Quote
NextGen Healthcare, Inc
$17.96 (-0.83%) $0.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.